10x Genomics (FRA:1KJ) 3-Year EBITDA Growth Rate : 29.90% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics 3-Year EBITDA Growth Rate?

10x Genomics's EBITDA per Share for the three months ended in Dec. 2023 was €-0.27.

During the past 3 years, the average EBITDA Per Share Growth Rate was 29.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of 10x Genomics was 44.10% per year. The lowest was -214.00% per year. And the median was 0.80% per year.

Competitive Comparison of 10x Genomics's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, 10x Genomics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10x Genomics's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where 10x Genomics's 3-Year EBITDA Growth Rate falls into.

10x Genomics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

10x Genomics (FRA:1KJ) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

10x Genomics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of 10x Genomics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics (FRA:1KJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (FRA:1KJ) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

TXG:USA 1KJ:Germany

Address

6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588

Website

https://www.10xgenomics.com

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics (FRA:1KJ) Headlines

No Headlines